Role of Amyloid A in atherosclerosis risk prediction
Keywords:
Serum ionizedCa, serum amyloid A, serum CRPAbstract
Background The study attempts to find a predictive and diagnostic method for atherosclerosis through its relationship with atherosclerosis and general inflammation Aim Determine the serum amyloid A and highly sensitive c- reactive protein(CRP) level in early diagnostic parameters of acute phase reactant protein of patients with a low level of ionizedCawho represent the category at risk of atherosclerosis. Subjects, Material and Method The patients were divided into two groups according to the level ofionizedCa more than 4 (mg/dl)and less than 4(mg/dl), their ages ranged between (50-60 years), and tested them for serum ox-LDL,troponin, amyloid A and CRP. Results It can notice a significant (p ≤ 0.05) increase inacute phase proteins serum CRP Mean ± SD (200 ± 20.28) (mg/L), and amyloid A (2.8 ± 7.88) (mg/L) before the rise in serum troponin (97.19 ± 9.9) (ng /L), which was found to be nonsignificant (p > 0.05) at this stage, with a decrease in the level of Ca-ionized less than 4 (mg/dl). Conclusion It can be considered serum amyloid A as well asc- reactive protein (CRP) a diagnostic biomarker for the future of atherosclerosis events assuming that atherosclerosis risk is associated with low serum ionizedCalevel.
Downloads
References
Sack, G.H. (2020). Serum Amyloid A (SAA) Proteins. In: Hoeger, U.,
Harris, J. (eds) Vertebrate and Invertebrate Respiratory Proteins,
Lipoproteins, and other Body Fluid Proteins. Subcellular
Biochemistry, vol 94. Springer, Cham., pp 421-436.
Shridas P, Tannock LR., 2019. Role of serum amyloid A in
atherosclerosis. Curr Opin Lipidol. 30(4):320-325.
Alfaddagh, A., Martin, S.S., Leucker, T.M., Michos, E.D., Blaha, M.J.,
Lowenstein, C.J., Jones, S.R. and Toth, P.P., 2020. Inflammation and
cardiovascular disease: From mechanisms to therapeutics. American
journal of preventive cardiology, 4, p.100130.
Cozzolino, M., Ciceri, P., Galassi, A., Mangano, M., Carugo, S., Capelli, I.
and Cianciolo, G., 2019. The key role of phosphate on vascular
calcification. Toxins, 11(4), p.213.
Thankam, F.G., Radwan, M.M. and Agrawal, D.K., 2020. Inflammation and
epicardial adipose tissue in the pathobiology of atherogenesis and
neointimal hyperplasiafollowing coronaryintervention.In Biochemistryof
cardiovascular dysfunction in obesity (pp. 235-266).
Papa, R. and Lachmann, H.J., 2018. Secondary, AA,
amyloidosis. Rheumatic Disease Clinics, 44(4), pp.585-603.
Medina-Leyte, Diana Jhoseline, Oscar Zepeda-Garcia, Mayra
Dominguez-Perez, Antonia Gonzalez-Garrido, Teresa VillarrealMolina, and Leonor Jacobo-Albavera. 2021. "Endothelial
Dysfunction, Inflammation and Coronary Artery Disease: Potential
Biomarkers and Promising Therapeutical Approaches" International
Journal of Molecular Sciences 22, no. 8: 3850.
Collado, A., Domingo, E., Piqueras, L. and Sanz, M.J., 2021. Primary
hypercholesterolemia and development of cardiovascular disorders:
Cellular and molecular mechanisms involved in low-grade systemic
inflammation and endothelial dysfunction. The International
Journal of Biochemistry & Cell Biology, 139, p.106066.
Saleh, S.A. and Al-Alwany, A.A., 2022. The Clinical Profile and Coronary
Artery Findings in Patients with Atrial Fibrillation. Journal of the
Faculty of Medicine, 64(1).
Nehring SM, Goyal A, Patel BC.C Reactive Protein. In: StatPearls [Internet].
Treasure Island (FL):StatPearls Publishing; 2022. Accessed 5/17/2022.
Al Alwany, A.A., 2022. Effect and benefit of percutaneous coronary
intervention in chronic total occlusion on ventricular repolarization:
QT correction and dispersion. Journal of Medicine & Life, 15(8).
Takashio,S.,Yamamuro,M.,Izumiya,Y., Hirakawa, IC,Marume,K.,Yamamoto,M.,
Ueda, M., Yamashita, T., Ishibashi Ueda, H., Yasuda, S. and Ogawa, H., 2018.
Diagnostic utility of cardiac troponin T level in patients with cardiac
amyloidosis.ESC heart failure, 5(1), pp.27-35.
Ahmadi, A., Panahi, Y., Johnston, T.P. and Sahebkar, A., 2021.
Antidiabetic drugs and oxidized low-density lipoprotein: A review of
anti-atherosclerotic mechanisms. Pharmacological Research, 172,
p.105819.
Khatana, C., Saini, N.K., Chakrabarti, S., Saini, V.,Sharma, A., Saini, R.V.
and Saini, A.K., 2020. Mechanistic insights into the oxidized lowdensity lipoprotein-induced atherosclerosis. Oxidative medicine and
cellular longevity, Volume 2020, Article ID 5245308, 14 pages.
Dhara, K. and Mahapatra, D.R., 2020. Review on electrochemical sensing
strategies for C-reactive protein and cardiac troponin I
detection. Microchemical Journal, 156, p.104857.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
